散发性甲状腺髓样癌的基因组与转录组特征分析
研究纳入29例散发性甲状腺髓样癌(sMTC)患者,对18例肿瘤及配对非癌组织行全外显子组测序,全部29例肿瘤行全转录组测序。结果显示RET是唯一反复出现的癌症相关体细胞突变基因(5/18,27.8%),FAT1/FAT4胚系突变常见且常伴4q染色体缺失(4/18,22.2%),敲低FAT1/FAT4可促进MTC细胞增殖;基于表达谱可分间充质样和增殖样两个分子亚型,80%的结构性复发事件发生于增殖样亚型。
要点
- RET是sMTC唯一反复出现的癌症相关体细胞突变基因(5/18,27.8%)。
- FAT1/FAT4胚系突变常见,且FAT1/FAT4体细胞染色体缺失见于4/18(22.2%)。
- sMTC可分间充质样与增殖样两个分子亚型,80%结构性复发见于增殖样亚型。
核心结论
- 除RET外,FAT1/FAT4基因组改变在sMTC中似乎较常见。
- 可识别出具有不同生物学行为的两个sMTC分子亚型。
- 这些结果需未来通过更大样本和更全面实验验证,尤其是FAT1/FAT4胚系变异的频率和功能。
研究设计与样本
- 研究纳入29例sMTC患者,对18例患者的肿瘤样本及配对非癌组织行全外显子组测序(WES)。
- 对全部29例肿瘤行全转录组测序(RNA-Seq),并分析WES、RNA-Seq及拷贝数改变(CNA)数据。
- 采用Cell Counting Kit-8(CCK-8)实验评估细胞增殖。
主要发现
- 体细胞突变中,RET是唯一反复出现的癌症相关突变基因(5/18,27.8%)。
- 胚系中FAT1和FAT4(FAT基因家族成员)为两个最常见的突变基因。
- CNA分析发现位于染色体4q的FAT1和FAT4也是体细胞染色体缺失最常累及的基因之二(4/18,22.2%)。
- 使用TT和MZ-CRC-1细胞系,CCK-8实验显示敲低FAT1和FAT4可促进MTC细胞增殖。
- 基于基因表达谱,患者被聚类为两个分子亚型:间充质样亚型以上皮-间充质转化为特征,增殖样亚型与细胞周期通路富集相关。
关键数值与推荐
- 体细胞RET突变频率为5/18(27.8%)。
- FAT1/FAT4体细胞染色体缺失频率为4/18(22.2%)。
- 结构性复发事件中80%发生于增殖样亚型。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文指出这些结果需未来通过更大样本和更全面实验验证。
- 尤其需验证FAT1/FAT4胚系变异的频率和功能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Sporadic medullary thyroid carcinoma (MTC) is a relatively uncommon neuroendocrine malignancy and the molecular tumorigenesis of its sporadic type (sMTC) is only partially understood. In this study, we performed a study focusing on the genomic and transcriptomic characterization of sMTC. Methods: Twenty-nine sMTC patients were included. Whole-exome sequencing (WES) was carried out in 18 patients, including both tumor samples and matched noncancerous tissues. Whole transcriptome sequencing (RNA-Seq) was performed in all 29 tumors. WES, RNA-Seq, and copy number alteration (CNA) data were analyzed. A Cell Counting Kit-8 (CCK-8) assay was used to evaluate cell proliferation. Results: Among the somatic mutations, RET was the only recurrently cancer-related mutated gene (5/18, 27.8%). In the germline, FAT1 and FAT4, two members of the FAT gene family, were identified as the two most common mutated genes. CNA analysis found that FAT1 and FAT4, both located on chromosome 4q, were also two of the genes most commonly affected by somatic chromosomal deletions (4/18, 22.2%). Using TT and MZ-CRC-1 cell lines, the CCK-8 assay showed that FAT1 and FAT4 knockdown could promote MTC cell proliferation. Based on the gene expression profile, patients were clustered into two molecular subtypes: the mesenchymal-like subtype is characterized by epithelial-mesenchymal transition, while the proliferative-like subtype is associated with enrichment of cell cycle pathways. Most events of structural recurrence (80%) occurred in the proliferative-like subtype. Conclusion: In addition to RET, these findings demonstrate that FAT1/FAT4 genomic alterations appear to be frequent in sMTC. Two molecular subtypes of sMTC with distinct biological behavior could be identified. However, these results need to be validated by larger samples and more comprehensive experiments in the future, especially for the frequency and function of FAT1/FAT4 germline variants.
引用
- Qu N, Shi X, Zhao JJ, et al. Genomic and Transcriptomic Characterization of Sporadic Medullary Thyroid Carcinoma. Thyroid. 2020. PMID: 32031055. doi:10.1089/thy.2019.0531
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。